Kumquat Biosciences describes new GTPase KRAS inhibitors for cancer
Dec. 1, 2023
Kumquat Biosciences Inc. has identified GTPase KRAS and KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer, particularly solid tumors and hematological cancer.